mBio · 2024 · 10 citations · 121 references
MedicineInfectious DiseasesPharmacologyDrug DiscoveryMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral ResistanceAntiviral TherapyAntiviral Agent SelectionAntiviral Drug DesignAntiviral Drug MechanismsAntiviral Structure-activity RelationshipsAntiviral TherapeuticsAntiviral TreatmentInfluenza Antiviral TherapyInfluenza Treatment
Influenza viruses (IVs) threaten global human health due to the high morbidity, infection, and mortality rates. Currently, the influenza drugs recommended by the Food and Drug Administration are oseltamivir, zanamivir, peramivir, and baloxavir marboxil. These recommended antivirals are currently effective for major subtypes of IVs as the compounds target conserved domains in neuraminidase or polymerase acidic (PA) protein. However, this trend may gradually change due to the selection of antiviral drugs and the natural evolution of IVs. Therefore, there is an urgent need to develop drugs related to the treatment of influenza to deal with the next pandemic. Here, we summarized the cutting-edge research in mechanism of action, inhibitory activity, and clinical efficacy of drugs that have been approved and drugs that are still in clinical trials for influenza treatment. We hope this review will provide up-to-date and comprehensive information on influenza antivirals and generate hypotheses for screens and development of new broad-spectrum influenza drugs in the near future.
121
Rational design of potent sialidase-based inhibitors of influenza virus replication
Mark von Itzstein, Wen‐Yang Wu, Gaik B. Kok et al. · Nature · 1993 · 1.9K citations
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert, Gira Bhabha, Marc‐André Elsliger et al. · Science · 2009 · 1.4K citations · Full text
Choung U. Kim, Willard Lew, Matthew A. Williams et al. · Journal of the American Chemical Society · 1997 · 1.1K citations
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
Frederick G. Hayden, Norio Sugaya, Nobuo Hirotsu et al. · New England Journal of Medicine · 2018 · 929 citations · Full text